Alexandria Venture Investments, LLC — SEC insider filings
SEC reporting owner CIK 1722024. 18 insider filings on record with FilingPulse; latest filed 2026-10-15.
Transaction summary — filings shown
Covers all 18 filings on record, filed 2020-08-25 to 2026-10-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 3,760,510 shares, $7,499,981 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 6 legs across 3 filings — 875,000 shares, $2,620,925 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
- Largest priced transaction: purchase of 178,571 shares @ $14.00 ($2,499,994) in TRex Bio, Inc., filed 2026-10-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Applied Therapeutics, Inc. (APLT) | 10% owner | 8 | 3 legs · 3,543,478 sh · $4,499,994 | 6 legs · 875,000 sh · $2,620,925 | 14 |
| TRex Bio, Inc. (TRXB) | 10% owner | 2 | 1 leg · 178,571 sh · $2,499,994 | — | 3 |
| Metacrine, Inc. (MTCR) | 10% owner | 1 | 1 leg · 38,461 sh · $499,993 | — | 4 |
| Kymera Therapeutics, Inc. (KYMR) | 10% owner | 1 | — | — | 3 |
| Silverback Therapeutics, Inc. (SBTX) | 10% owner | 1 | — | — | 3 |
| Singular Genomics Systems, Inc. (OMIC) | 10% owner | 1 | — | — | 3 |
| Vigil Neuroscience, Inc. (VIGL) | 10% owner | 1 | — | — | 3 |
| Vor Biopharma Inc. (VOR) | 10% owner | 1 | — | — | 2 |
| Xilio Therapeutics, Inc. (XLO) | 10% owner | 1 | — | — | 2 |
| GreenLight Biosciences Holdings, PBC (GRNA) | — | 1 | — | — | 1 |
Insider filings — Alexandria Venture Investments, LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-15 | 4 | TRex Bio, Inc. (TRXB) | Conversion (C): 1,167,930 · Purchase (P): 178,571 @ $14 · Conversion (C): 1,033,541 (derivative) @ $0 · Conversion (C): 3,480,387 (derivative) @ $0 | EDGAR |
| 2026-10-08 | 3 | TRex Bio, Inc. (TRXB) | Holdings only — no transactions reported | EDGAR |
| 2024-06-06 | 4 | Applied Therapeutics, Inc. (APLT) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC | Sale (S): 150,000 @ $4.21 · Sale (S): 150,000 @ $4.24 | EDGAR |
| 2023-12-01 | 4 | Applied Therapeutics Inc. (APLT) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC | Other (J): 575,000 · Other (J): 575,000 | EDGAR |
| 2023-11-06 | 4 | Applied Therapeutics Inc. (APLT) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC | Sale (S): 103,808 @ $2.32 · Sale (S): 143,450 @ $2.31 | EDGAR |
| 2023-11-02 | 4 | Applied Therapeutics Inc. (APLT) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC | Sale (S): 155,000 @ $2.41 · Sale (S): 172,742 @ $2.36 | EDGAR |
| 2023-10-16 | 4 | Applied Therapeutics Inc. (APLT) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC | Other (J): 1,600,000 · Other (J): 1,600,000 · Other (J): 615,000 (derivative) · Other (J): 615,000 (derivative) | EDGAR |
| 2023-07-26 | 4 | GreenLight Biosciences Holdings, PBC (GRNA) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC. | Other (J): 1,609,909 @ $0 | EDGAR |
| 2022-06-29 | 4 | Applied Therapeutics Inc. (APLT) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC | Purchase (P): 1,435,000 @ $1 · Purchase (P): 2,065,000 @ $1 · Purchase (P): 615,000 (derivative) @ $1.00 · Purchase (P): 885,000 (derivative) @ $1.00 · Purchase (P): 2,050,000 (derivative) · Purchase (P): 2,950,000 (derivative) | EDGAR |
| 2022-02-25 | 4 | Applied Therapeutics Inc. (APLT) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC | Other (J): 300,000 · Other (J): 300,000 | EDGAR |
| 2022-01-11 | 4 | Vigil Neuroscience, Inc. (VIGL) | Conversion (C): 192,973 · Conversion (C): 392,618 (derivative) @ $0 · Conversion (C): 142,539 (derivative) @ $0 | EDGAR |
| 2021-10-26 | 4 | Xilio Therapeutics, Inc. (XLO) | Conversion (C): 166,423 · Conversion (C): 1,581,026 (derivative) | EDGAR |
| 2021-06-01 | 4 | Singular Genomics Systems, Inc. (OMIC) | Conversion (C): 2,645,985 @ $0 · Conversion (C): 1,796,684 (derivative) · Conversion (C): 849,301 (derivative) | EDGAR |
| 2021-02-19 | 4 | Applied Therapeutics Inc. (APLT) jointly with ALEXANDRIA REAL ESTATE EQUITIES, INC., Alexandria Equities No. 7, LLC | Purchase (P): 43,478 @ $23 · Other (J): 43,478 · Other (J): 43,478 | EDGAR |
| 2021-02-09 | 4 | Vor Biopharma Inc. (VOR) | Conversion (C): 282,804 · Conversion (C): 3,846,152 (derivative) | EDGAR |
| 2020-12-08 | 4 | Silverback Therapeutics, Inc. (SBTX) | Conversion (C): 699,412 · Conversion (C): 1,428,570 (derivative) · Conversion (C): 1,168,347 (derivative) | EDGAR |
| 2020-09-18 | 4 | Metacrine, Inc. (MTCR) | Conversion (C): 1,268,795 · Purchase (P): 38,461 @ $13 · Conversion (C): 4,599,997 (derivative) · Conversion (C): 1,107,899 (derivative) · Conversion (C): 762,961 (derivative) | EDGAR |
| 2020-08-25 | 4 | Kymera Therapeutics, Inc. (KYMR) | Conversion (C): 467,932 · Conversion (C): 500,000 (derivative) · Conversion (C): 246,305 (derivative) | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1722024 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs